Loading...
16 Genetic Disorder Drugs Reports
Study Period: 2019 - 2030
Regions Covered: North America, Europe, Asia-Pacific, Middle East and Africa, South America
Major Players: AstraZeneca, GlaxoSmithKline, Merck, Pfizer, Valerio Therapeutics
Study Period: 2019 - 2030
Regions Covered: North America, Europe, Asia Pacific, Middle East and Africa, South America
Major Players: Bayer, Pfizer, Takeda Pharmaceuticals, Sanofi, Novo Nordisk
Study Period: 2019 - 2030
Regions Covered: North America, Europe, Asia Pacific, Middle East and Africa, South America
Major Players: Biomarin Pharmaceutical, CSL Behring, Roche, Novo Nordisk, Pfizer
Study Period: 2020 - 2030
Regions Covered: North America, Europe, Asia Pacific, Middle East and Africa, South America
Major Players: Bayer, Novartis, Pfizer, Sanofi, Bluebird Bio
Study Period: 2019 - 2030
Regions Covered: North America, Europe, Asia Pacific, Middle East and Africa, South America
Major Players: CSL Behring, Grifols, Octapharma, Bio Products Laboratory, Takeda (Shire)
Study Period: 2019 - 2030
Regions Covered: North America, Europe, Asia-Pacific, Middle East and Africa, South America
Major Players: Takeda Pharmaceuticals, CSL Behring, Pharming Group NV, BioCryst Pharmaceuticals, KalVista Pharmaceuticals
Study Period: 2021 - 2030
Regions Covered: North America, Europe, Asia Pacific
Major Players: NIPPON SHINYAKU CO., LTD. (NS Pharma Inc.), ITALFARMACO S.p.A., PTC Therapeutics, Santhera Pharmaceuticals, Sarepta Therapeutics
Study Period: 2019 - 2030
Regions Covered: North America, Europe, Asia Pacific, Middle East and Africa, South America
Major Players: Bluebird Bio, Novartis, ApoPharma, Bellicum Pharmaceuticals, Pfizer
Study Period: 2019 - 2030
Regions Covered: North America, Europe, Asia Pacific, Middle East and Africa, South America
Major Players: Novartis, Emmaus Medical, Sanofi, Bluebird bio, Inc., Pfizer
Study Period: 2019 - 2030
Regions Covered: North America, Europe, Asia Pacific, Middle East and Africa, South America
Major Players: Pfizer, Alnylam Pharmaceuticals, Intellia Therapeutics, Inc., AstraZeneca, BridgeBio Pharma Inc
Study Period: 2019 - 2030
Regions Covered: North America, Europe, Asia Pacific, Middle East and Africa, South America
Major Players: Pfizer, Alnylam Pharmaceuticals, Teva Pharmaceutical Industries, Neurocrine Biosciences, Ionis Pharmaceuticals
Study Period: 2019 - 2030
Regions Covered: North America, Europe, Asia Pacific
Major Players: Sanofi, Takeda Pharmaceuticals, Amicus Therapeutics, ISU ABXIS, JCR Pharmaceuticals
Study Period: 2019 - 2030
Regions Covered: North America, Europe, Asia-Pacific, Middle East and Africa, South America
Major Players: Sanofi, Global Blood Therapeutics, Bluebird Bio, EMI Holding, Celgene
Study Period: 2019 - 2030
Regions Covered: North America, Europe, Asia Pacific, Middle East and Africa, South America
Major Players: Amicus Therapeutics, Sanofi, Exerkine Corporation, Genethon, Maze Therapeutics, Inc.
Study Period: 2021 - 2030
Regions Covered: North America, Europe, Asia Pacific, Middle East and Africa, South America
Major Players: REGENXBIO, Clinigen Group, JCR Pharmaceuticals, ArmaGen, Takeda Pharmaceuticals
Study Period: 2019 - 2030
Regions Covered: North America, Europe, Asia-Pacific, Middle East and Africa, South America
Major Players: Abbvie, Gilead Sciences, Vertex Pharmaceuticals Inc., Alaxia SAS, Mylan NV (Viatris)
Filter Reports
By Region
By Countries
